ClinConnect ClinConnect Logo
Search / Trial NCT06587412

Treatment of Lateral Epicondylalgia With Shock Waves

Launched by UNIVERSITY OF ALCALA · Sep 4, 2024

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying two types of shockwave therapy to help people with lateral epicondylalgia, commonly known as tennis elbow. This condition causes pain on the outer part of the elbow, weakness in the wrist, and difficulty with everyday activities. The trial aims to compare the safety and effectiveness of radial shockwave therapy and focal shockwave therapy to see which one works better for relieving pain and improving function. Participants will be assessed for pain levels, grip strength, and disability before and after treatment, with follow-up evaluations taking place over six months.

To be eligible for this study, participants should have had pain in their elbow for more than three months and experience pain when gripping objects. Unfortunately, those who are pregnant, have certain medical conditions like diabetes or arthritis, or have recently received specific treatments will not be able to participate. If you join the trial, you will take part in three treatment sessions, each one week apart, and you may receive either one of the shockwave therapies or a placebo treatment that doesn’t involve any active therapy. This study is currently recruiting participants of all genders between the ages of 25 and 66.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Pain in the lateral epicondyle \>3 months
  • Pain when performing resisted grip
  • Positive Cozen test
  • Positive Maudsley test
  • Exclusion Criteria:
  • Pregnancy
  • Systemic diseases (Fibromyalgia, Diabetes, Arthritis)
  • Local infection or Cancer
  • Recent treatments (Physiotherapy, Corticosteroids)-

About University Of Alcala

The University of Alcalá, a prestigious institution located in Spain, is committed to advancing medical research and innovation through its clinical trial sponsorship. With a strong emphasis on interdisciplinary collaboration and ethical standards, the university leverages its academic expertise and state-of-the-art facilities to facilitate groundbreaking studies in various fields of healthcare. By fostering partnerships with industry leaders and healthcare professionals, the University of Alcalá aims to enhance patient outcomes and contribute to the global body of medical knowledge. Its dedication to rigorous research methodologies ensures the integrity and reliability of clinical trials, promoting a culture of excellence in scientific inquiry.

Locations

Alcalá De Henares, Madrid, Spain

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported